1998
DOI: 10.1016/s0002-9149(98)00531-1
|View full text |Cite
|
Sign up to set email alerts
|

Metabolic derangement in ischemic heart disease and its therapeutic control

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
26
0
6

Year Published

1999
1999
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(33 citation statements)
references
References 54 publications
1
26
0
6
Order By: Relevance
“…So far, therapeutic attempts to prevent reperfusion injury are limited to relatively smallscale studies testing the administration of vitamin E (24), calcium antagonists (25), early use of ACE inhibitors, sulfhydrylrich reagents such as N-acetylcysteine, magnesium, and various free radical scavengers (26). However, accelerated myocyte necrosis and destruction related to reoxygenation of the ischemic myocardium continues to represent a clinically relevant question.…”
Section: Discussionmentioning
confidence: 99%
“…So far, therapeutic attempts to prevent reperfusion injury are limited to relatively smallscale studies testing the administration of vitamin E (24), calcium antagonists (25), early use of ACE inhibitors, sulfhydrylrich reagents such as N-acetylcysteine, magnesium, and various free radical scavengers (26). However, accelerated myocyte necrosis and destruction related to reoxygenation of the ischemic myocardium continues to represent a clinically relevant question.…”
Section: Discussionmentioning
confidence: 99%
“…Mitochondrial dysfunction in ischemia-reperfusion injury is caused by oxidative stress (1)(2)(3)(4)(5)(6). In the post-ischemic heart, oxygen delivery to the myocardium is not sufficient to meet the need for mitochondrial oxidation during the physiological conditions of hypoxia, leaving the mitochondrial electron transport chain (ETC) 2 in a more reduced state.…”
mentioning
confidence: 99%
“…Multiple factors are likely to have a role in the protective effect of ACE inhibitors in ischemia-reperfusion injury: they decrease leukocyte infiltration 28 , possess anti-inflammatory effects 29 and free radical scavenging properties 30 , and effect mediated by increase the levels of bradykinin and prostaglandin 31 . Because ACE inhibition can increase circulating levels of angiotensin-(1-7) 32 , this may mediate some of these cardiovascular effects 33,34 .…”
Section: Discussionmentioning
confidence: 99%